No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.

University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?

Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
Find out more in a Simmaron Research Foundation sponsored blog:
Print Friendly, PDF & Email

HISTORIC Action to Double NIH Funding For ME/CFS Under Way


After years of work it’s time to attempt what we’ve never been able to do before – get Congress to force the NIH to double its funding for ME/CFS. Support the historic bill to increase research funding, add new ME/CFS research centers, require the development of a strategic plan, etc.. It will take less than 5 minutes.

Be a part of making history. Find out more about the effort here and join it here. 

Don't Miss Another Blog!

Like this blog?

Make sure you don’t miss another  one by registering for our free ME/CFS and Fibromyalgia blogs here..

Pin It on Pinterest

Share This